“DEVELOPMENT OF FUZZY INFERENCE SYSTEM FOR COVID-19 DATA ANALYSIS”, Journal of Pharmaceutical Negative Results, vol. 13, no. 4, pp. 693–699, Oct. 2022, doi: 10.47750/pnr.2022.13.04.093.